[2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
D035843:Biomedical Research; D002271:Carbutamide; D004361:Drug Tolerance; D007004:Hypoglycemic Agents; D010600:Pharmacology; D011743:Pyrimidines; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides; D014044:Tolbutamide
D007004:Hypoglycemic Agents; D011743:Pyrimidines; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D014044:Tolbutamide; D002271:Carbutamide; C030986:pyrimidine
ANTIDIABETICS; CARBUTAMIDE; CLINICAL RESEARCH; DRUG TOLERANCE; PHARMACOLOGY; PYRIMIDINES; SULFONAMIDES; TOLBUTAMIDE
2-BENZOLSULFONAMIDO-5(BETA-METHOXY-AETHOXY)-PYRIMIDIN (GLYCODIAZIN) EIN NEUES ORALES ANTIDIABETICUM.